Clinical trials
Observational Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 10 |
| Unknown status | 7 |
| Not yet recruiting | 3 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Gasthuisberg | 7 |
| Universitaire Ziekenhuizen KU Leuven | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| General Hospital Groeninge | 2 |
| Hasselt University | 2 |
| Jules Bordet Institute | 2 |
| KU Leuven | 2 |
| University Hospital, Ghent | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Alphatec Spine, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 47 |
| Breast Neoplasms | 8 |
| Lung Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Head and Neck Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Squamous Cell | 2 |
| Colonic Neoplasms | 2 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.